Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Aurinia Pharmaceuticals Inc AUPH

Healthcare Biotechnology
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.


NDAQ:AUPH - Post by User

Aurinia Pharmaceuticals Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
  • TimeScapeX
Comment by TimeScapeon Nov 22, 2021 3:28pm
261 Views
Post# 34154179

RE:WTH ? Happened today ?

RE:WTH ? Happened today ?Aurinia announced a possible large financing Friday after the close.  Obviously, if they are doing a financing, they aren't going to be bought out.  The price simply dropped back to what it was before the takeover rumours started.  I sold 40% of my position at $33.50.  Still have the other 60%.  Will be interesting to see how rapidly the sales for lupkinis ramp up.  That's what will move the stock price now.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities